Biopharma Update on the Novel Coronavirus: October 27
The Pharma Data
OCTOBER 26, 2020
FDA Actions. FDA Approval: Last week the FDA approved Veklury (remdesivir) for the treatment of COVID-19 requiring hospitalization in adults and pediatric patients (12 years of age and older). The approval marks the first drug approved by the U.S. Testing Therapies, Antivirals and Vaccines.
Let's personalize your content